New Index Rates Drug Companies in Fight Against ‘Superbugs’ by DONALD G. McNEIL Jr.


Glaxo and Johnson & Johnson top a new measure of how drugmakers do against antibiotic-resistant bacteria, which are becoming a global emergency.

Published: January 23, 2018 at 01:00AM

from NYT Health https://ift.tt/2Dxuy4Y